AMPK activation reduces cancer cell aggressiveness via inhibition of monoamine oxidase A (MAO-A) expression/activity.

[1]  A. Bhattacharjee,et al.  IL-13 and the hydroperoxy fatty acid 13(S)HpODE play crucial role in inducing an apoptotic pathway in cancer cells involving MAO-A/ROS/p53/p21 signaling axis. , 2022, Free radical biology & medicine.

[2]  Lin F. Yang,et al.  The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet.

[3]  B. Tyler,et al.  Metformin and Cancer, an Ambiguanidous Relationship , 2022, Pharmaceuticals.

[4]  Ted E. Natoli,et al.  A network based efficient drug repurposing strategy for targeting diabesity , 2022, Genes and Diseases.

[5]  Peng Zhang,et al.  SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis , 2021, Oncogene.

[6]  S. Lentz,et al.  Alkaline intracellular pH (pHi) activates AMPK–mTORC2 signaling to promote cell survival during growth factor limitation , 2021, The Journal of biological chemistry.

[7]  C. Klein.  Cancer progression and the invisible phase of metastatic colonization , 2020, Nature Reviews Cancer.

[8]  M. Fares,et al.  Molecular principles of metastasis: a hallmark of cancer revisited , 2020, Signal Transduction and Targeted Therapy.

[9]  D. Fingar,et al.  AMPK directly activates mTORC2 to promote cell survival during acute energetic stress , 2019, Science Signaling.

[10]  Othman Soufan,et al.  NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis , 2019, Nucleic Acids Res..

[11]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[12]  M. Nireekshan Kumar,et al.  Genome‐wide mRNA–miRNA profiling uncovers a role of the microRNA miR‐29b‐1‐5p/PHLPP1 signalling pathway in Helicobacter pylori‐driven matrix metalloproteinase production in gastric epithelial cells , 2018, Cellular microbiology.

[13]  K. Biswas,et al.  Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13–stimulated monocytes and A549 lung carcinoma cells , 2018, The Journal of Biological Chemistry.

[14]  Albert-László Barabási,et al.  Network-based approach to prediction and population-based validation of in silico drug repurposing , 2018, Nature Communications.

[15]  D. Mishra,et al.  Small cell and non small cell lung cancer form metastasis on cellular 4D lung model , 2018, BMC Cancer.

[16]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[17]  C. Pan,et al.  MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells , 2017, Scientific Reports.

[18]  C. Pan,et al.  MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions. , 2017, Cancer cell.

[19]  W. Rathmell,et al.  AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and Survival. , 2016, Cell metabolism.

[20]  Thomas C Chen,et al.  Monoamine oxidase A (MAO A) inhibitors decrease glioma progression , 2016, Oncotarget.

[21]  A. Barabasi,et al.  Network-based in silico drug efficacy screening , 2016, Nature Communications.

[22]  B. Brüne,et al.  AMP-activated Protein Kinase Suppresses Arachidonate 15-Lipoxygenase Expression in Interleukin 4-polarized Human Macrophages* , 2015, The Journal of Biological Chemistry.

[23]  Mickael Guedj,et al.  Analysis of drug combinations: current methodological landscape , 2015, Pharmacology research & perspectives.

[24]  M. White,et al.  Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase , 2015, Cell.

[25]  Bin Zhang,et al.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..

[26]  Kara Dolinski,et al.  The BioGRID interaction database: 2015 update , 2014, Nucleic Acids Res..

[27]  C. Deng,et al.  SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells , 2014, Molecular Cancer Therapeutics.

[28]  Takla Griss,et al.  Differential effects of AMPK agonists on cell growth and metabolism , 2014, Oncogene.

[29]  Chun-Peng Liao,et al.  Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. , 2014, The Journal of clinical investigation.

[30]  F. Cheng,et al.  Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy , 2014, Oncotarget.

[31]  Rafael C. Jimenez,et al.  The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases , 2013, Nucleic Acids Res..

[32]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[33]  Haiyuan Yu,et al.  INstruct: a database of high-quality 3D structurally resolved protein interactome networks , 2013, Bioinform..

[34]  Inyoung Kim,et al.  Targeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy , 2013, Front. Oncol..

[35]  T. Yap,et al.  Development of therapeutic combinations targeting major cancer signaling pathways. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  A. Rajput,et al.  Intra-Tumoral Heterogeneity in Metastatic Potential and Survival Signaling between Iso-Clonal HCT116 and HCT116b Human Colon Carcinoma Cell Lines , 2013, PloS one.

[37]  Hsien-Da Huang,et al.  dbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications , 2012, Nucleic Acids Res..

[38]  Karin Breuer,et al.  InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation , 2012, Nucleic Acids Res..

[39]  H. Sakurai,et al.  SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice. , 2012, Oncology reports.

[40]  H. Ke,et al.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases , 2012, Cell.

[41]  A. Pandey,et al.  Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. , 2012, Molecular bioSystems.

[42]  I. Wistuba,et al.  The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  B. Martín-Castillo,et al.  Metformin: Multi-faceted protection against cancer , 2011, Oncotarget.

[44]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[45]  Jianmin Wu,et al.  PINA v2.0: mining interactome modules , 2011, Nucleic Acids Res..

[46]  J. Shih,et al.  Transcriptional regulation and multiple functions of MAO genes , 2011, Journal of Neural Transmission.

[47]  R. Day,et al.  Clinical Pharmacokinetics of Metformin , 2011, Clinical pharmacokinetics.

[48]  Cathryn M. Gould,et al.  Phospho.ELM: a database of phosphorylation sites—update 2011 , 2010, Nucleic Acids Res..

[49]  G. Feldman,et al.  Monocyte 15-Lipoxygenase Gene Expression Requires ERK1/2 MAPK Activity , 2010, The Journal of Immunology.

[50]  Yuehua Wu,et al.  Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress. , 2010, Cellular signalling.

[51]  M. Loda,et al.  Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer , 2010, British Journal of Cancer.

[52]  S. Hawley,et al.  Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation , 2010, Cell metabolism.

[53]  R. Garofalo,et al.  SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦ , 2010, The Journal of Biological Chemistry.

[54]  Shu-Chen Lu,et al.  Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity , 2009, Chemical biology & drug design.

[55]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[56]  P. Puigserver,et al.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.

[57]  Ming Yi,et al.  bioDBnet: the biological database network , 2009, Bioinform..

[58]  V. Sartorelli,et al.  Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues , 2008, Cell cycle.

[59]  N. Ruderman,et al.  SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1 , 2008, Journal of Biological Chemistry.

[60]  Fan Lan,et al.  SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.

[61]  A. Thompson,et al.  Targeting AMPK: a new therapeutic opportunity in breast cancer. , 2008, Critical reviews in oncology/hematology.

[62]  Xu Huang,et al.  Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. , 2008, The Biochemical journal.

[63]  T. Hei,et al.  Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. , 2008, Experimental cell research.

[64]  Amy V. Lynch,et al.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.

[65]  A. Leslie,et al.  Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols , 2007, Proceedings of the National Academy of Sciences.

[66]  D. Neil Hayes,et al.  LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.

[67]  Z. Marković,et al.  Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis , 2007, Cellular and Molecular Life Sciences.

[68]  S. Yamawaki,et al.  Antidepressants Increase Glial Cell Line-Derived Neurotrophic Factor Production through Monoamine-Independent Activation of Protein Tyrosine Kinase and Extracellular Signal-Regulated Kinase in Glial Cells , 2007, Journal of Pharmacology and Experimental Therapeutics.

[69]  X. Ou,et al.  Glucocorticoid and Androgen Activation of Monoamine Oxidase A Is Regulated Differently by R1 and Sp1* , 2006, Journal of Biological Chemistry.

[70]  X. Ou,et al.  Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Brian C. Smith,et al.  Mechanism of Human SIRT1 Activation by Resveratrol* , 2005, Journal of Biological Chemistry.

[72]  Dario R Alessi,et al.  Metformin and reduced risk of cancer in diabetic patients , 2005, BMJ : British Medical Journal.

[73]  S. Choi,et al.  R1, a Novel Repressor of the Human Monoamine Oxidase A* , 2005, Journal of Biological Chemistry.

[74]  D. Hardie.  The AMP-activated protein kinase pathway – new players upstream and downstream , 2004, Journal of Cell Science.

[75]  M. Blagosklonny,et al.  Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy , 2004, Cell cycle.

[76]  D. Sidransky,et al.  LKB1 protein expression in the evolution of glandular neoplasia of the lung. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[77]  G. Feldman,et al.  Interleukin-13 Induction of 15-Lipoxygenase Gene Expression Requires p38 Mitogen-Activated Protein Kinase-Mediated Serine 727 Phosphorylation of Stat1 and Stat3 , 2003, Molecular and Cellular Biology.

[78]  David Sidransky,et al.  Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.

[79]  B. Han,et al.  Establishment of Cell Lines with High and Low Metastatic Potential from A549 Human Lung Adenocarcinoma , 2002, Japanese journal of cancer research : Gann.

[80]  G. D. De Zutter,et al.  Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[81]  E. Appella,et al.  Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase , 2001, Nature.

[82]  M. Cathcart,et al.  Induction of 15-Lipoxygenase Expression by IL-13 Requires Tyrosine Phosphorylation of Jak2 and Tyk2 in Human Monocytes* , 1998, The Journal of Biological Chemistry.

[83]  P. Cohen,et al.  Participation of a stress-activated protein kinase cascade in the activation of tyrosine hydroxylase in chromaffin cells. , 1997, European journal of biochemistry.

[84]  Jin Zhang,et al.  PhosphoNetworks: a database for human phosphorylation networks , 2014, Bioinform..

[85]  D. Zack,et al.  Supplementary Information Construction of Human Activity-Based Phosphorylation Networks , 2013 .

[86]  S. Kundu,et al.  IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. , 2013, Free radical biology & medicine.

[87]  Dipanwita Roy Chowdhury,et al.  Human protein reference database as a discovery resource for proteomics , 2004, Nucleic Acids Res..

[88]  J. Shih,et al.  Monoamine oxidase: from genes to behavior. , 1999, Annual review of neuroscience.